The University of Lausanne (UNIL) and the École Polytechnique Fédérale de Lausanne (EPFL) are pleased to announce a call for proposals to award one exceptional collaborative project in the field of genomic, precision medicine, cancer or translation neurosciences.
This award is made possible thanks to a donation from the Société Académique Vaudoise supported by the Novartis Consumer Health Foundation for the advancement of the biological, medical and pharmaceutical sciences.
The program at a glance
This call for proposals is conceived to establish or strengthen research collaboration between UNIL and EPFL researchers within the fields of genomic, precision medicine, cancer or translational neurosciences. One project will be funded with up to CHF 303’680.- for up to 24 months.
- Deadline: 31 October 2018.
- Awards will be made public by end of December 2018.
- Earliest start of the project: February – April 1, 2019.
This call is dedicated to applied research proposals in the general areas of genomic, precision medicine, cancer or translational neurosciences.
Proposals must be collaborative: one principal investigator at UNIL and one principal investigator at EPFL.
Established senior scientists from UNIL and EPFL are invited to apply: full professors, associate professors, PATT (EPFL), PAST and PAST PTC (UNIL), adjunct professors, MER, SNSF-funded professors and senior scientists. The host institutions must employ the PI for the entire duration of the project.
Please have a look at the application guidelines.
Research proposals should be in the topic of genomic, precision medicine, cancer or translational neurosciences.
Scientific excellence of the research proposal.
Originality/Innovative nature of the project (in relation to the relevant state-of-the-art).
Excellence of the applicants.
Impact of the proposal on the relevant scientific field and on the long-term collaboration between a research group at UNIL and at EPFL.
Preference will be given to new projects. Proposals to continue ongoing work in a laboratory will be less favorably reviewed.
For more information on the evaluation criteria and the evaluation committee, please have a look at the call guidelines.